Differing roles of inflammatory factors
A new study indicates that treatments that regulate inflammatory factors might be more beneficial in eyes with major branch retinal vein occlusion (BRVO) than in eyes with macular BRVO. The study involved 40 patients with macular oedema due to major branch retinal vein occlusion (BRVO) or macular BRVO who were treated by pars plana vitrectomy. Measurement of their vitreous fluid levels of inflammatory factors showed that eyes with major BRVO had higher concentrations of the inflammatory factors VEGF and sICAM-1, compared with eyes with macular BRVO, but eyes with macular BRVO had higher levels of the anti-inflammatory factor PEDF, compared to eyes with major BRVO.
(Noma et al, Ophthalmologica 2012; DOI:10.1159/000335047).
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.